ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 291

Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study

Helena Andersson1, Eva Kirkhus2, Else Merckoll2, Ragnhild Walle-Hansen3 and Øyvind Molberg1, 1Department of Rheumatology, Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway, 2Department of Radiology, Oslo University Hospital, Oslo, Norway, 3Department of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: MRI and myositis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Muscle MRI is used to describe the myositis component of the anti-synthetase syndrome (ASS), but the value of the examination is limited by lack of reference data from non-myositis populations. The primary aim of this study was therefore to compare the MRI findings in ASS with healthy age- and gender matched controls.

Methods:

In September 2011, 68/70 ASS patients in the Oslo University Hospital ASS cohort were included in a comparative, cross-sectional study that included muscle MRI, manual muscle testing of 24 muscles (MMT24) and plasma CK. Sex and age-matched healthy controls were randomly collected from the National People Register of Norway in a 1:1 proportion (N=67).  MRI was using a 1.5 T scanner with coronal and axial T1-weighted spin echo and short T1 inversion recovery (STIR) sequences of thigh muscles. The images were analyzed by two radiologists blinded for the participant’s status. Edema in muscles or fascia was evaluated as present/not present. Fatty infiltration was scored according to the Guttalier grading (0-4) and considered pathological if > 2 [1]. Elevated CK was defined as > 2x upper limit of normal (ULN). The MMT24 score (0-140) was performed by two experienced physiotherapists. Chi-Square and Mann Whitney U-test were used to evaluate statistical significance (p<0.05). Pearson’s correlation was used to detect correlations.

Results:

Median disease duration for the ASS patients was 71 months and 76% had previously been diagnosed with myositis. Abnormal MRI findings were found in 63% of the patients compared to 18 % in the controls with significant differences in the proportion of muscle and fascia edema, as well as fatty infiltration (Table 1). The MRI findings in the control group were to some extent asymmetric. Median MMT24 scores were lower in ASS than controls, but CK levels did not differ between the groups (Table 1). In ASS patients no correlation was seen between muscle-edema and elevated CK or between MMT24 and elevated CK. MRI abnormalities were detected in 35/52 ASS patients with myositis and in 7/15 cases with no previous myositis signs. There was no difference in MMT24 or CK values between the two ASS subsets. Of the 12 controls with abnormal MRI findings, only one had elevated CK and three had MMT24 score ≤ 137.

Table 1; MRI findings, MMT24 and CK levels in ASS patients and matched controls

 

ASS

N=68

Controls

N=67

p-value

MRI findings n/N (%)

 

 

 

A  Edema in muscles

26/67 (39)

7/66 (11)

<0.001

B  Edema in fascia

19/67 (28)

5/66 (8)

<0.003

C  Fatty infiltration

25/67 (37)

3/66 (5)

<0.001

A, B and/or C

42/67 (63)

12/66 (18)

<0.001

Other muscle parameters

 

 

 

Median CK, U/ml (range)

95 (24-1344)

98 (35-839)

   <0.676

CK> 2x ULN, n/N (%)

4/67 (6)

1/65 (2)

   <0.366

Median MMT24 score (range)

139 (114-140)

140 (130-140)

   <0.001

 

 

Conclusion:

This comparative study reports significant differences in myositis-related MRI findings between ASS patients and matched controls. Muscle-edema was present in 37% of ASS patients with normal CK but only in 10% of the controls. The study shows that MRI has potential as a complementary tool to assess myositis in ASS, and highlights the need for MRI scoring systems that differentiate patients from controls.

References;

1. Goutallier, D., et al., Influence of cuff muscle fatty degeneration on anatomic and functional outcomes after simple suture of full-thickness tears. J Shoulder Elbow Surg, 2003. 12(6): p. 550-4.


Disclosure: H. Andersson, None; E. Kirkhus, None; E. Merckoll, None; R. Walle-Hansen, None; Molberg, None.

To cite this abstract in AMA style:

Andersson H, Kirkhus E, Merckoll E, Walle-Hansen R, Molberg . Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/correlations-between-muscle-mri-muscle-strength-and-creatine-kinase-levels-in-the-anti-synthetase-syndrome-a-comparative-cross-sectional-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlations-between-muscle-mri-muscle-strength-and-creatine-kinase-levels-in-the-anti-synthetase-syndrome-a-comparative-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology